Company
United StatesPublic company, NYSE: BLCOBausch & Lomb Incorporated (NYSE: BLCO), Lancaster, NY – FDA Inspections
Inspection records and compliance data for Bausch & Lomb Incorporated in Lancaster, New York. 3 FDA inspections on record, 1 Form 483, last inspected February 15, 2017. Publicly traded as NYSE: BLCO.
Company Profile
This profile covers Bausch & Lomb Incorporated based in Lancaster, New York, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected June 9, 2010. Last inspected February 15, 2017.
Most cited issue areas
- Records of complaint investigation1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 15, 2017 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1001173 |
| December 9, 2014 | NAI | Medical Devices & Rad Health · Compliance: Devices | 909049 |
| June 9, 2010 | NAI | Medical Devices & Rad Health · Compliance: Devices | 667094 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bausch & Lomb Incorporated
Stock ticker
BLCO
Exchange
NYSE
Share price
$19.96
Market cap
$7.1B
Price as of
November 6, 2026
FEI Number
1315522
Address
6 Lancaster Pkwy, Lancaster, New York 14086, United States
Country
United States
ID: 922a39c8-5fdc-4a83-81ca-b036bfd32784